Acetylsalicylic acid is the chemical name for aspirin, one of the most widely used medications in history and arguably the most studied drug ever made. At its core, acetylsalicylic acid works by permanently disabling an enzyme called cyclooxygenase, which the body needs to produce prostaglandins, the chemical messengers behind pain, inflammation, fever, and blood clotting. That single mechanism has made it useful for everything from headaches to heart attack prevention, though the same chemistry also accounts for its well-known side effects.
From Willow Bark to a White Tablet
The roots of acetylsalicylic acid stretch back more than 3,500 years. Sumerians and Egyptians used willow bark as a painkiller, and physicians in ancient Greece and Rome continued the practice.1PubMed. The first 3500 years of aspirin history from its roots – A concise summary The active ingredient in that bark is salicin, which the body converts to salicylic acid. Salicylic acid works, but it is brutally hard on the stomach. In 1897, a Bayer chemist named Felix Hoffmann added an acetyl group to salicylic acid, creating acetylsalicylic acid, a compound that was gentler on the gut while retaining the therapeutic punch. For another 70 years, though, nobody understood exactly how the drug worked. That mystery was finally solved in the early 1970s, when the pharmacologist John Vane showed that aspirin inhibits prostaglandin production, a discovery that later earned him a Nobel Prize.2PubMed. The aspirin story – from willow to wonder drug
How Acetylsalicylic Acid Works
The drug’s mechanism is unusual among painkillers because it is irreversible. Acetylsalicylic acid transfers its acetyl group to a specific amino acid (a serine at position 530) inside the cyclooxygenase enzyme, physically blocking the spot where the enzyme’s natural substrate would normally bind.3PubMed Central. Residual cyclooxygenase activity of aspirin-acetylated COX-2 forms 15 R-prostaglandins that inhibit platelet aggregation Once acetylated, the enzyme is shut down for good. The cell has to make entirely new copies to resume prostaglandin production. This matters most for platelets, the tiny blood cells involved in clotting, because platelets have no nucleus and cannot manufacture fresh enzyme. A single dose of aspirin disables platelet cyclooxygenase for the entire seven-to-ten-day lifespan of that platelet.4ACS Catalysis. Understanding the Molecular Details of the Mechanism That Governs the Oxidation of Arachidonic Acid Catalyzed by Aspirin-Acetylated Cyclooxygenase‑2
Because prostaglandins are involved in pain signaling, inflammation, fever regulation, stomach lining protection, and blood clot formation, shutting down their production has broad consequences, both therapeutic and unwanted. Anti-inflammatory, analgesic, and antipyretic effects have all been traced directly to this single biochemical action.5Journal of Allergy and Clinical Immunology. The mode of action of aspirin and similar compounds
Aspirin for the Heart
The irreversible antiplatelet effect is what made aspirin a mainstay of cardiology. After a heart attack or stroke, daily low-dose aspirin reduces the risk of another vascular event by roughly a quarter in people with established cardiovascular disease.6PubMed Central. Aspirin resistance: a clinical review focused on the most common cause, noncompliance Early pharmacological work showed that even low doses could completely suppress platelet thromboxane production for over 24 hours.7PubMed. Inhibition of prostacyclin and platelet thromboxane A2 after low-dose aspirin
Where things get contentious is primary prevention, meaning giving aspirin to people who have never had a heart attack or stroke. Aspirin protects against clot-driven events, but it also increases the risk of serious bleeding. In large population studies, that trade-off does not clearly favor aspirin for otherwise healthy people.8PubMed Central. Aspirin for the Primary Prevention of Cardiovascular Disease: Time for a Platelet-Guided Approach Despite this, primary prevention aspirin use remains common. A Danish study tracking over a million adults found that roughly 3% were still using low-dose aspirin for primary prevention as of 2018, with the rate climbing to about one in five among people over 80. Bleeding rates were highest in that elderly group, at around two major bleeds per hundred patient-years, and about a fifth of all aspirin users were simultaneously taking other medications that increase bleeding risk.9PubMed Central. Low-dose aspirin for primary and secondary prevention of cardiovascular events in Denmark 1998-2018 The overall trend in medical guidance has been moving away from routine primary prevention aspirin, especially for older adults.
Pain Relief Compared to Other Over-the-Counter Options
As a painkiller, aspirin is effective but not dramatically so. A pooled analysis of head-to-head analgesic studies found that a higher dose of aspirin (around 1,000 mg) was modestly better than a lower dose (around 500 mg), but the improvement was small. The same analysis compared the dose-response curves of aspirin, ibuprofen, and acetaminophen and found a similar pattern across all three: doubling the dose produced a real but modest bump in pain relief.10PubMed Central. Dose–response in direct comparisons of different doses of aspirin, ibuprofen and paracetamol (acetaminophen) in analgesic studies In practice, most people reach for ibuprofen or acetaminophen today for everyday pain, partly because aspirin is harder on the stomach and partly because the other options have become more familiar.
The Stomach Problem
Gastric irritation is aspirin’s oldest and best-known side effect. It turns out to be a two-pronged attack. First, when aspirin is swallowed, it is quickly broken down into salicylic acid, which is directly toxic to stomach lining cells. Second, by inhibiting cyclooxygenase, aspirin shuts off the production of prostaglandins that normally help protect the stomach by stimulating mucus and bicarbonate secretion. These two effects work together to make the lining more vulnerable to acid damage.11PubMed. Aspirin-induced gastric mucosal injury: lessons learned from animal models
This is exactly why enteric-coated aspirin was developed. The coating prevents the tablet from dissolving in the stomach, delaying absorption until the small intestine. But the evidence on whether this actually helps is less encouraging than you might expect. While enteric coating does produce fewer visible erosions in the stomach on endoscopy, it causes similar erosions in the small intestine instead, and it does not reduce the rate of clinically significant ulcers or gastrointestinal bleeding.12PubMed Central. Pharmacological Efficacy and Gastrointestinal Safety of Different Aspirin Formulations for Cardiovascular Prevention: A Narrative Review A secondary analysis of the large ADAPTABLE trial found no meaningful difference in either safety or effectiveness between enteric-coated and plain aspirin in patients with cardiovascular disease.13JAMA Cardiology. Effectiveness and Safety of Enteric-Coated vs Uncoated Aspirin in Patients With Cardiovascular Disease: A Secondary Analysis of the ADAPTABLE Randomized Clinical Trial
Enteric coating introduces another problem: weaker antiplatelet activity. Because the drug is absorbed further along the digestive tract at a higher pH, bioavailability drops, and the resulting inhibition of platelet function can be inadequate, especially in heavier individuals.14PubMed. Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers So enteric-coated aspirin may protect the stomach less than advertised while simultaneously doing a worse job of preventing clots.
Aspirin and Children
One of the most important safety lessons in aspirin’s history involves Reye’s syndrome, a rare but devastating condition in children characterized by brain swelling and fatty infiltration of the liver. It typically appears a few days after a viral infection like influenza or chickenpox.15JAMA Pediatrics. Aspirin and Reye’s Syndrome A series of case-control studies in the early 1980s found a strong link between aspirin use during viral illness and the development of Reye’s syndrome. In one Michigan study, nearly all children who developed the condition had received aspirin during their preceding illness, compared to a smaller proportion of matched controls.16JAMA. Aspirin as a Risk Factor in Reye’s Syndrome
The biochemical explanation involves a generalized disruption of mitochondrial metabolism, leading to metabolic failure in the liver and other organs.17PubMed. Aspirin and Reye syndrome: a review of the evidence Public health warnings issued in the 1980s led to a dramatic drop in pediatric aspirin use, and Reye’s syndrome has since become extremely rare. Today, aspirin is generally avoided in children and teenagers with febrile illnesses, with acetaminophen and ibuprofen used instead.
Aspirin-Exacerbated Respiratory Disease
A smaller but clinically significant group of people experiences respiratory reactions to aspirin: wheezing, nasal congestion, and sometimes severe asthma attacks. This condition, known as aspirin-exacerbated respiratory disease, typically occurs in adults who already have asthma and nasal polyps. The mechanism is distinct from a true allergic reaction. In affected individuals, blocking cyclooxygenase with aspirin removes a natural brake on leukotriene production. Specifically, the loss of prostaglandin E2, which normally inhibits an enzyme called 5-lipoxygenase, allows mast cells to activate unchecked, triggering the respiratory symptoms.18World Journal of Otorhinolaryngology – Head and Neck Surgery. Pathogenesis of NSAID-induced reactions in aspirin-exacerbated respiratory disease This means the reaction is a pharmacological consequence of how aspirin works in these particular people, not an immune-mediated allergy, though the symptoms can be just as serious.
When People Are Called “Aspirin Resistant”
You may hear the term “aspirin resistance” used to describe patients who seem not to benefit from the drug’s antiplatelet effects. The label suggests some innate biological refusal to respond. In reality, the most common reason by far is noncompliance: people are not actually taking their aspirin as prescribed. When adherence is properly accounted for, true biochemical non-response is uncommon.19PubMed Central. Aspirin resistance: a clinical review focused on the most common cause, noncompliance That said, some variability in drug absorption and platelet turnover does exist, and factors like enteric coating and body weight can reduce the drug’s antiplatelet effect. Calling this “resistance” medicalizes what is often a compliance or formulation issue.
Aspirin Overdose
Because aspirin is available without a prescription and sits in nearly every medicine cabinet, accidental or intentional overdose remains a real clinical concern. In toxic amounts, salicylate disrupts the body’s energy production at a fundamental level, uncoupling the process cells use to make ATP and interfering with key metabolic enzymes. Patients may develop a characteristic pattern of breathing too fast (the body’s attempt to blow off carbon dioxide to counteract acid buildup), along with nausea, vomiting, ringing in the ears, confusion, and in severe cases, seizures, pulmonary edema, and coma.20PubMed Central. Acute Salicylate Toxicity: A Narrative Review for Emergency Clinicians The metabolic picture can be paradoxical: blood sugar can swing high or low, and the body can be simultaneously alkalotic and acidotic depending on the stage of poisoning.21JAMA Internal Medicine. Acute and Chronic Effects of Aspirin Toxicity and Their Treatment Chronic overdose, which happens when someone takes slightly too much over days or weeks, can be harder to recognize than a single large ingestion because the symptoms (confusion, tinnitus, subtle breathing changes) mimic other conditions in older adults.
Drug Interactions Worth Knowing About
Aspirin does not exist in a vacuum, and many of its problems arise from what people take alongside it. A prospective study in community pharmacies found that the most common drug interaction flagged was between low-dose aspirin and other NSAIDs like ibuprofen, with ibuprofen involved in over 40% of detected interaction cases. The patients at risk tended to be older (average age 68) and were taking a median of five other medications. Anticoagulants, which independently raise bleeding risk, were part of the mix in about one in six cases.22PubMed. Prevalence and management of drug interactions between nonsteroidal anti-inflammatory drugs and antithrombotics in ambulatory care The practical concern is that taking ibuprofen around the same time as aspirin can actually block aspirin’s access to the cyclooxygenase enzyme in platelets, undermining the very cardiac protection the aspirin was prescribed for. If you use both, timing matters, and it is worth discussing the specifics with a pharmacist.
Potential Role in Cancer Prevention
One of the more intriguing developments in aspirin research involves colorectal cancer. Low-dose aspirin has been shown to produce long-lasting acetylation of cyclooxygenase in human colorectal tissue, and this is accompanied by changes in signaling pathways involved in early tumor growth.23PubMed. Low-Dose Aspirin Acetylates Cyclooxygenase-1 in Human Colorectal Mucosa: Implications for the Chemoprevention of Colorectal Cancer The idea is that chronic low-level suppression of prostaglandin-driven inflammation in the gut lining could slow the progression of pre-cancerous cells. This has led some medical bodies to consider aspirin as a chemopreventive agent for people at elevated colorectal cancer risk, though the bleeding trade-off means it has not become a blanket recommendation for the general population.
Pre-eclampsia Prevention in Pregnancy
Low-dose aspirin has found a specific and well-supported niche in obstetrics. Women at high risk for pre-eclampsia, a dangerous pregnancy complication involving high blood pressure and organ damage, may be started on low-dose aspirin early in pregnancy. In one study, women who received aspirin had a pre-eclampsia rate of about 9%, compared to roughly 29% in the control group, a relative risk reduction close to 70%.24Scientific Reports. Early initiation of low-dose aspirin for the prevention of pre-eclampsia in high-risk pregnancies The mechanism likely involves aspirin’s effects on prostacyclin and thromboxane balance in the placental blood vessels. This is one area where the risk-benefit math clearly favors aspirin use, and guidelines in many countries now recommend it for high-risk pregnancies when started before 16 weeks of gestation.
Aspirin and Dementia
Whether aspirin protects the brain against cognitive decline is a question that has generated genuinely conflicting evidence. Observational studies have pointed toward a benefit: a meta-analysis of such studies found that low-dose aspirin was associated with a roughly 25% lower likelihood of developing dementia and an even greater reduction specifically for Alzheimer’s disease.25PubMed Central. Aspirin Use on Incident Dementia and Mild Cognitive Decline: A Systematic Review and Meta-Analysis But when the analysis was restricted to randomized controlled trials, the association vanished. The ASPREE trial, a large placebo-controlled study in older adults, found no benefit from low-dose aspirin for dementia, mild cognitive impairment, or cognitive decline over nearly five years of follow-up.26PubMed Central. Antiplatelets and Vascular Dementia: A Systematic Review
There may be a subgroup for whom the picture is different. A large cohort analysis found that the strongest protective effect of long-term low-dose aspirin on dementia appeared in people who already had coronary heart disease, with substantial reductions in risk for both vascular dementia and Alzheimer’s disease in that group specifically. In the general population without heart disease, there was no meaningful protection.27PubMed Central. Long-term low-dose acetylsalicylic use shows protective potential for the development of both vascular dementia and Alzheimer’s disease in patients with coronary heart disease but not in other individuals from the general population: results from two large cohort studies One plausible explanation is that in people with cardiovascular disease, aspirin’s antiplatelet effects prevent small clots and microvascular damage in the brain that would otherwise accumulate over years. In people without that underlying vascular pathology, there is less damage for aspirin to prevent.
Salicylic Acid in the Plant Kingdom
Aspirin’s parent compound, salicylic acid, did not evolve to serve human medicine. In plants, salicylic acid is a critical hormone that regulates growth, development, and defense against pathogens.28PubMed. Systemic Acquired Resistance and Salicylic Acid: Past, Present, and Future When a plant leaf gets infected by a pathogen, salicylic acid acts as a mobile signal, traveling from the infected tissue to uninfected parts of the plant through the fluid between cells. This triggers a broad defensive response called systemic acquired resistance, essentially the plant equivalent of an immune system activation.29PubMed Central. Salicylic Acid and Mobile Regulators of Systemic Immunity in Plants: Transport and Metabolism The compound that humans borrowed from willow bark to treat headaches is, in its native context, part of an ancient plant immune strategy. Some gardeners even dissolve aspirin tablets in water and spray the solution on plants, hoping to prime their defenses, though the evidence for this as a practical gardening technique is thin.
Aspirin as an Environmental Contaminant
Given that billions of aspirin tablets are consumed globally each year, it is not surprising that acetylsalicylic acid and its metabolites end up in waterways. After use, aspirin is excreted partly in its original form and partly as metabolites, which enter aquatic ecosystems through wastewater. Monitoring surveys have detected NSAIDs including acetylsalicylic acid in surface waters worldwide at concentrations in the nanogram-to-microgram per liter range.30PubMed. Toxicity of the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) acetylsalicylic acid, paracetamol, diclofenac, ibuprofen and naproxen towards freshwater invertebrates: A review Those concentrations are far too low to cause acute toxicity, but chronic exposure is a different matter. A study exposing freshwater fish to environmentally relevant concentrations of aspirin over four weeks found significant oxidative stress in the liver, disrupted antioxidant defenses, and visible tissue damage that worsened with both concentration and duration of exposure.31PubMed. Ecotoxicological impacts of environmentally relevant concentrations of aspirin in the liver of Labeo rohita: Biochemical and histopathological investigation Aspirin is not usually singled out as the worst pharmaceutical pollutant (other NSAIDs like diclofenac get more attention in ecotoxicology), but its sheer volume of use means it contributes to the cocktail of active drug residues in freshwater systems. The fact that a molecule designed to interfere with prostaglandin signaling in humans can disrupt similar pathways in fish is not exactly a shock, but it is a reminder that what we flush does not simply disappear.